Predictors of acute effectiveness of subcutaneous implantable cardioverter-defibrillator according to the implantation technique

17 March 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Pietro Francia

Sapienza University of Rome, Rome (Italy)

9 More presentations in this session

Presentation thumbnail

Refining ICD decision-making in non-ischaemic patients in the post-DANISH era: analysis from a nationwide database of daily remote-monitoring transmissions in a real-world cohort

Doctor G. Forleo (Milan, IT)

Abstract Slides Video

Presentation thumbnail

Long-term performance of contemporary internal cardioverter defibrillator leads: a single center experience

Doctor R. Brenner (St. Gallen, CH)

Abstract Slides Video

Presentation thumbnail

Incidence of appropriate therapy and mortality after ICD generator replacement: results from a real-world nationwide prospective cohort

Doctor M. Ruwald (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Myocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous implantable cardioverter-defibrillators.

Ms A. Quast (Amsterdam, NL)

Abstract Slides Video

Presentation thumbnail

Depression and anxiety during the first 12 months post-implant: a matched cohort study of patients with a subcutaneous implantable defibrillator and patients with a transvenous system

Professor S. Schmidt Pedersen (Odense, DK)

Abstract Slides Video

Access the full session

Session thumbnail

Rapid Fire 4: The shocking truth of device therapy

The Event

EHRA 2019

17 March - 19 March 2019

You may be interested in

Congress Presentation

Implantable cardioverter-defibrillator

Congress Presentation

When to consider device therapy in HFrEF - discussion

Congress Session

Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources